ABBOTT LABORATORIES (ABT) Operating margin 2016–2025
ABBOTT LABORATORIES (ABT) operating margin by fiscal year — reported operating income divided by reported revenue.
18.2%FY2025 · since FY2016: 14.5% → 18.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 18.2% | +1.9 pp |
| FY2024 | 16.3% | +0.1 pp |
| FY2023 | 16.2% | -3.0 pp |
| FY2022 | 19.2% | -0.4 pp |
| FY2021 | 19.6% | +4.1 pp |
| FY2020 | 15.5% | +1.3 pp |
| FY2019 | 14.2% | +2.3 pp |
| FY2018 | 11.9% | +6.2 pp |
| FY2017 | 5.7% | -8.8 pp |
| FY2016 | 14.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice